Orbital solitary fibrous tumors: a multi-centered histopathological and immunohistochemical analysis with radiological description.

Background: Solitary fibrous tumors (SFT), formerly called hemangiopericytoma, are rare tumors derived from mesenchymal cells originally described in the pleura, but these tumors may affect extraserosal tissues including the lacrimal gland and orbit.
Objective: Conduct a multi-centered clinical, radiological and histopathological analysis of 17 orbital SFT cases.
Design: A retrospective case series.
Setting: Three eye centers in two countries.
Patients and Methods: The data collected from the charts of 17 adult patients presenting with tissue diagnosis of orbital hemangiopericytoma or SFT from January 2003 to December 2018 included demographics, clinical imaging and histopathological information including immunohistochemical (IHC) characteristics.
Main Outcome Measures: The demographic characteristics, clinical presentation, and histopathological patterns or variants of SFT were analyzed.
Sample Size: 17 adult patients.
Results: Mean age was 45 years (range 23-80 years). Male to female ratio was 3:1. The right eye was affected in 12 (70.5%) patients. Commonest presentation was proptosis in 13/17 (76% of patients). Other symptoms were impaired motility (29%) and ptosis (11%). Lesions mostly affected the medial orbit (35%), then orbital apex in 11%. The histopathological classic pattern-less variant was the commonest. One case with aggressive behavior, multiple recurrences and atypical features was encountered. Immunohistochemical (IHC) markers used included CD34 expression in all cases, Bcl-2 expression in 10/11, CD99 in 9/9 and Vimentin in 4/4. STAT6 was used in 2 cases.
Conclusions: SFTs are rare tumors affecting the orbit in both genders equally in their mid-forties, but showed male predominance in our analysis with a predominant classic histopathological pattern. Tissue diagnosis is essential and requires IHC studies for confirmation.
Limitations: Sample size is relatively small owing to the rarity of this tumor in the orbit.
Conflict of Interest: None.